News Release Details

Jun 7, 2016
Magellan Health to Present at Barclays Select Series Pharmacy Benefit Management & Drug Pricing Symposium

SCOTTSDALE, Ariz.--(BUSINESS WIRE)-- Magellan Health, Inc. (NASDAQ: MGLN) announced today that Todd Lord, vice president of clinical strategy at Magellan Rx Management, the company's pharmacy benefit management division, will participate in two panel discussions at the Barclays Select Series Pharmacy Benefit Management and Drug Pricing Symposium in New York on Wednesday, June 15, 2016 from 11:15 a.m.-12:15 p.m. Eastern. The panels will cover the following topics: Value-based Pricing Initiatives and Formulary Innovation-What to Watch for 1/1/2017.

About Magellan Health: Headquartered in Scottsdale, Ariz., Magellan Health, Inc. is a leader in managing the fastest growing, most complex areas of health, including special populations, complete pharmacy benefits and other specialty areas of healthcare. Magellan develops innovative solutions that combine advanced analytics, agile technology and clinical excellence to drive better decision making, positively impact health outcomes and optimize the cost of care for the members we serve — all within a customer-first culture. Magellan's customers include health plans and other managed care organizations, employers, labor unions, various military and governmental agencies and third-party administrators. For more information, visit

Magellan Health, Inc.
Media Contact:
Colleen Flanagan Johnson, 860-507-1923
Investor Contact:
Renie Shapiro Silver, 877-645-6464

Source: Magellan Health, Inc.

News Provided by Acquire Media